Main text
To investigate kavalactone biosynthesis, we first surveyed the occurrence of kavalactones in kava ( Figure 1A ) and four related Piper species by liquid-chromatography mass-spectrometry (LC-MS). While kavalactones are among the most abundant metabolites found in kava, they are absent in the other examined species ( Figure 1B) , suggesting their underlying biosynthetic machinery likely emerged after the diversification of the Piper genus. We also detected flavokavain A, B, and C in kava, which are specialized chalconoids with reported anti-cancer Kava is a decaploid (2n = 10x = 130 chromosomes) 12 , rendering biosynthetic inquiry via conventional genetic approaches infeasible. We therefore turned to a multi-omics-guided candidate gene approach [13] [14] [15] . We first identified three CHS -like genes in a kava transcriptome assembled de novo from leaf and root tissues (Supplementary Table 1 ). Phylogenetic analysis of these genes in the context of other land plant CHS s suggests that two of the three genes were likely derived from recent gene duplication events specific to kava ( Figure 3A) . In vitro enzyme assays using heterologously expressed and purified enzymes established that these two CHS -like genes indeed encode functional SPSs. Both enzymes exclusively produce the triketide lactone bisnoryangonin from p -coumaroyl-CoA ( Figure 3B ), and are therefore named Pm SPS1 and Pm SPS2 hereafter. The assay also established that the third CHS -like gene encodes a bona fide CHS, which produces the expected tetraketide-derived naringenin chalcone, and is referred to as Pm CHS hereafter ( Figure 3B ). It is noted that Pm CHS also produces p -coumaroyltriacetic acid lactone (CTAL) and bisnoryangonin in addition to naringenin chalcone in vitro , although similar derailment products have been reported for a number of previously characterized CHSs 16 .
To assess the in vivo function of the three newly identified kava PKSs, we expressed each of them as stable transgenes in the Arabidopsis thaliana CHS -null mutant tt4-2 background 17 .
While PmCHS restored flavonoid biosynthesis in tt4-2 , neither PmSPS1 nor PmSPS2 did, consistent with their respective in vitro biochemical activities ( Figure 4 To probe the mechanistic basis for SPS neofunctionalization from the ancestral CHS, we solved the apo structure of Pm CHS and the holo structure of Pm SPS1 in complex with p -coumaroyl-CoA by X-ray crystallography (Table 1) . Both proteins are homodimers and share the canonical αβαβα thiolase fold typical for plant type III PKSs 11 ( Figure 3C ). An evolutionary analysis using the Mixed Effects Model of Evolution (MEME) 19 on the ancestral branch of kava SPSs ( Figure 3A ) detected six amino acid residues under episodic diversifying selection (p<0.05) ( Figure 5 ). Three of these substitutions, S133C, T198N, and Q213L, are mapped to the enzyme active site ( Figure 3D) . Notably, the T198N substitution was previously reported as one of the three mutations sufficient to convert CHS into a 2-pyrone synthase (2PS) 20 . We also observed an unusual insertion of threonine (T194) in a loop region abutting the active site, together with the 4 S133C substitution, causing a reduction of the Pm SPS1 active site volume compared to Pm CHS in the direction along the polyketide chain elongation ( Figure 3E ). In comparison, the previously reported Rheum palmatum benzalacetone synthase ( Rp BAS) , which catalyzes only a single polyketide elongation 21 , features a further shortened active site compared to Pm SPS1
( Figure 3E ). These observations therefore support the notion that subtle changes of active site volume and shape of type III PKSs dictate the iterative cycles of polyketide elongation and alternative cyclization mechanisms 22 . In addition, we observed two different conformations of T194 among the six protomers present in the asymmetric unit, suggesting the dynamic nature of the underlying loop and its potential role in the catalytic cycle of Pm SPS1 ( Figure 3F) . One of the protomers in our Pm SPS1-p -coumaroyl-CoA complex structure also captures a p -coumaroyl-monoketide intermediate covalently bound to the catalytic cysteine ( Figure 3F ), providing a rare glimpse of the active site configuration after the starter substrate loading step of the PKS catalytic cycle 22 . Homology modeling and sequence analysis of Pm SPS2 suggest that its active site contains a similar set of amino acid substitutions as observed in Pm SPS1, except for the T194 insertion ( Figure 5 and 6).
Structures of naturally occuring kavalactones implicate rich O -methylation reactions during their biosynthesis ( Figure 2A ). We hypothesized that kavalactone biosynthetic OMTs could have been recruited from a conserved OMT involved in plant phenylpropanoid metabolism, e.g. the caffeic acid O -methyltransferase (COMT) in lignin biosynthesis 23 .
Combining phylogenomics and expression analysis, we identified six putative OMT candidate genes from kava transcriptomes (Supplementary Table 1 Importantly, the reduction of the 5,6-olefin occurs in a stereospecific manner, suggesting that this reaction is likely enzymatic. Using similar approaches as described above, we identified and characterized twelve kava reductases that are homologous to various known reductases in plant specialized metabolism (Supplementary Table 1 ). By transgenic co-expression of each of these reductase candidates together with PmSPS1 and PmKOMT1 in Nicotiana, we identified a single reductase candidate that produced metabolites with masses corresponding to reduced styrylpyrones (Supplementary Note 4). We thus named this enzyme k ava l actone r eductase 1 ( Pm KLR1). A combined enzyme assay using purified Pm 4CL1, Pm SPS1, Pm KOMT1, and Pm KLR1 enzymes starting from cinnamic acid successfully produced kavain in vitro ( Figure 8A ). Furthermore, we determined using chiral chromatography that Pm KLR1 produces only ( R )-(+)-kavain, the same stereoisomer as present in kava root extract ( Figure 8B ). We further established that Pm KLR1 can only accept unmethylated styrylpyrones, and is therefore competing with Pm KOMT1 for the same substrates ( Figure 9 ). This result provides an explanation to the fact that only some of the major kavalactones contain the reduced C 5 −C 6 bond ( Figure 2A ).
We hypothesized that the 7,8-saturated kavalactones could be derived from dihydro-hydroxycinnamoyl-CoA precursors already containing a reduced α−β bond. For example, two type III PKSs in the genera Pinus and Malus could accept dihydro-p -coumaroyl-CoA as a starter substrate to produce 5-hydroxylunularic acid and phloretin, respectively 24, 25 . To test this, we performed coupled Pm 4CL1− Pm SPS1 in vitro enzyme assays using phloretic acid or phenylpropanoic acid as starter substrates, both of which contain a reduced α−β bond. These assays resulted in the production of the corresponding 7,8-saturated kavalactones, respectively, suggesting that Pm 4CL1 and Pm SPS1 can utilize substrates derived from dihydro-hydroxycinnamic acids with a reduced α−β bond, which are common phenylpropanoid metabolites in plants ( Figure 10 ).
Methysticin-like kavalactones, which carry a methylenedioxy bridge at the C 11 −C 12 position (Figure 2A ), exhibit strong modulatory effects on human liver cytochromes P450, and thus contribute to the complex pharmacology of kava 26 . The CYP719 family of plant P450
enzymes is known to catalyze the formation of the methylenedioxy bridge moiety from vicinal methoxyl and hydroxyl groups, e.g. in the biosynthesis of berberine and etoposide 27, 28 . We Through OMT activity screen, we found that Pm KOMT1 and Pm KOMT2 also exhibit O -methylation activities against naringenin chalcone produced by CHS (Supplementary Note 6).
Using enzyme assays and heterologous expression in Nicotiana, we confirmed that Pm KOMT1 methylates the −OH groups at the C 4 and C 4' positions on the chalcone scaffold, while
Pm KOMT2 methylates the −OH group at the C 2' position ( Figure 11 ) . We thus established that the three known flavokavains ( Figure 2B ) are produced by the combinatorial activities of Pm CHS, Pm KOMT1, and Pm KOMT2.
As a proof of concept, we examined the feasibility of kavalactone production in microbial hosts through the means of metabolic engineering. Using an operon-like construct co-expressing Pm4CL1 with PmSPS1 or PmSPS2 under the constitutive pGAP promoter, we could reconstitute the biosynthesis of the kavalactone precursor, bisnoryangonin, from supplemented p -coumaric acid in E.coli under shake flask condition ( Figure 12A ). Similarly, plasmid-based expression of the same combination of enzymes under the constitutive pTEF promoter in the yeast
Saccharomyces cerevisiae also resulted in bisnoryangonin production from supplemented p -coumaric acid under shake flask condition ( Figure 12B ).
The kava extracts display complex pharmacology in animals, which include modulation of GABA A and cannabinoid (CB 1 ) receptors, blockade of voltage-gated sodium ion channels, reduced release and reuptake of several neurotransmitters, and interactions with monoamine oxidase B and liver cytochromes P450 4, 5, 26 . The capability to produce structurally diverse kavalactones and flavokavains using their biosynthetic enzymes described herein will help delineate the action mechanism and structure-function relationship of kavalactones. Furthermore, combinatorial biosynthesis using additional tailoring enzymes from other sources will further enable diversification of kavalactones for novel biomedical applications. In light of several major challenges facing modern society, such as anxiety, opioid crisis, and the scarcity of effective treatments for psychiatric disorders, kavalactones and their derivatives present a promising class of psychoactive molecules to potentially answer these unmet needs. 32 . Gene expression statistics were determined using RSEM 33 .
Materials and Methods
Transcripts and predicted protein sequences were annotated with transcript-per-million (TPM) values and closest BLAST hits from the UniProtKB/Swiss-Prot database using in-house scripts.
Transcriptome mining was performed on a local BLAST server 34 . In addition, two kava root Pm SPS1, Pm SPS2, Pm CHS, and Pm KLR1 proteins purified as homodimers, while Pm 4CL1, Pm KOMT1 and Pm KOMT2 purified as monomers.
In vitro enzyme assays. Enzyme assays were performed in 50 mM potassium phosphate buffer, pH 7.6 containing 5 mM MgCl 2 , 3 mM adenosine triphosphate (ATP), 1 mM coenzyme A, 3 mM malonyl-CoA, and 0.25 mM initial substrate (typically, cinnamic acid or p -coumaric acid).
Recombinant enzymes were added to final concentration of 10 µg/mL. For OMT assays, additional 3 mM S-adenosyl-methionine was added. For reductase assays, additional 5 mM reduced nicotinamide adenine dinucleotide phosphate (NADPH) was added. Reactions were incubated at 30 °C until completion (typically overnight), followed by the addition of methanol to 50% final concentration. Samples were centrifuged (13,000 g, 20 min) and supernatants were collected for LC-MS analyses.
Transgenic Arabidopsis . Kava PKS genes were cloned into the pEarleyGate 100 vector 42 and transformed into Agrobacterium tumefaciens strain GV3130. The Arabidopsis thaliana tt4-2 mutant 17 was then transformed using the Agrobacterium -mediated floral dip method 43 .
Transformants were selected by spraying with Finale (contains 11.33% glufosinate ammonium;
Bayer) diluted 1:500 in water. Selection was repeated in each subsequent generation and experiments were performed in the T2 or T3 generations.
qRT-PCR analysis. qRT-PCR reactions were performed on a QuantStudio 6 Flex system (Thermo Fisher Scientific) using SYBR Green Master Mix (Thermo Fisher Scientific) and primers listed in Supplementary Table 3 . Gene expression Ct values were normalized using the reference gene At1g13320 44 .
Plant metabolite extraction.
Approximately 100 mg of plant leaf tissue was dissected, transferred into grinding tubes containing ~15 zirconia/silica disruption beads (2 mm diameter;
Research Products International), and snap-frozen in liquid nitrogen. The frozen samples were homogenized twice on a TissueLyser II (QIAGEN). Metabolites were extracted using 5-10 volumes (w/v) of 50% methanol at 55 °C for 1 h. Extracts were centrifuged twice (13,000 g, 20 min) and supernatants were collected for LC-MS analysis. Source, Argonne National Laboratory). Diffraction intensities were indexed and integrated with iMosflm 49 and scaled with SCALA 50 . Initial phases were determined by molecular replacement using Phaser 51 in PHENIX 52 , using search models generated from protein sequences on the Phyre 2 server 53 . Subsequent structural building and refinements were conducted in PHENIX.
LC-MS analysis. LC was conducted on a Dionex
Coot was used for graphical map inspection and manual tuning of atomic models 54 . Root mean square deviation (RMSD) of Pm SPS1 and Pm CHS structures was calculated using the Structure comparison function in PHENIX. Crystallography statistics are listed in Table 1 .
Protein structure modeling and rendering. The Pm SPS2 structure model was generated on the Phyre 2 server using the Pm SPS1 X-ray structure as a modeling template 53 . The active site pocket in the Pm SPS1 structure was determined using KVFinder 55 . Molecular graphics were rendered with PyMOL (Schrödinger). Expression in Escherichia coli. Pm4CL1 , PmSPS1 , and PmSPS2 were cloned into a custom-made, operon-like expression vector pJKW1565. The genes were preceded by a constitutively expressed pGAP promoter of the E. coli glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 58 , and each gene was preceded by a 23-bp ribosome binding site (RBS) sequence 59 . tSPY was used as a terminator 60 . The constructed plasmids (pJKW1574 containing the Pm4CL1 + PmSPS1 operon and pJKW1658 containing the Pm4CL1 + PmSPS2 operon) were transformed into the BW27784 E. coli strain 61 and cultivated at 30 °C overnight in TB medium supplied with 1 mM p -coumaric acid, followed by metabolite extraction from the culture fluid. An aliquot of the bacterial culture was mixed with an equal volume of methanol (50% final methanol concentration), centrifuged twice (13,000 g, 20 min) and supernatants were collected for LC-MS analysis. Since bisnoryangonin standard was not available, its concentrations were estimated using naringenin as the calibration-curve standard.
Transient expression in
Expression in Saccharomyces cerevisiae . The p42xTEF 2µ plasmids with various auxotrophic growth markers for constitutive expression in yeast were used 62 . The Pm4CL1 gene was cloned into p425TEF (plasmid pJKW1413), while PmSPS1 and PmSPS2 were cloned into p426TEF
(plasmids pJKW1538 and pJKW1547, respectively). The constructed plasmids were transformed into the BY4743 yeast strain 63 . Yeast cells were cultivated at 30 °C for 2 days in Yeast Nitrogen Base (YNB) + histidine + dextrose medium supplied with 2 mM p -coumaric acid, followed by metabolite extraction from the culture fluid. An aliquot of the yeast culture was mixed with an equal volume of methanol (50% final methanol concentration), centrifuged twice (13,000 g, 20 min) and supernatants were collected for LC-MS analysis. Pm SPS2, and Pm CHS from a 4CL-coupled enzyme assay using p -coumaric acid as the starter substrate.
C. An overlay of the Pm CHS apo structure and the Pm SPS1-p -coumaroyl-CoA holo structure 
